1. Study shows effectiveness of micropulse TSCPC for glaucoma
A five-year study investigating the use of micropulse transscleral cyclophotocoagulation (TSCPC) and how it affects intraocular pressure (IOP) in patients with glaucoma has been published in Ophthalmology and Therapy.
The authors judged micropulse TSCPC to be safe and effective as a treatment for reducing IOP and the number of IOP-lowering medications required. It was also deemed a viable alternative for patients after failed incisional glaucoma surgery.
Researchers conducted a retrospective analysis of 165 patients with glaucoma in the Netherlands between 2016 and 2019.
The study saw an IOP reduction or a stable postoperative IOP with fewer medications in 70.8% of patients after five years.
Sign in to continue
Not already a member of the College?
Start enjoying the benefits of College membership today. Take a look at what the College can offer you and view our membership categories and rates.
We believe that vaccine uptake will be maximised when staff are supported to make their own decisions, having been provided with clear, evidence-based information on the benefit and value of vaccinations.